The Congressional Budget Office released its score of the American Healthcare Act (AHCA) today.
WASHINGTON – The Congressional Budget Office released its score of the American Healthcare Act (AHCA) today. This bill strips essential funding for people with substance use and behavioral health disorders in addition to losing access to comprehensive coverage and care.
Gary Mendell, the founder and CEO of Shatterproof, released this statement:
“The American Healthcare Act is a death sentence for people with substance use disorders who gained access to treatment under the Affordable Care Act. The House’s decision to incentivize states to roll back mandated coverage of essential health benefits, including treatment for substance abuse disorders, is unconscionable, as are the drastic cuts to Medicaid. The Senate must revise the bill to ensure that millions of Americans battling addiction can continue to receive the life-saving treatment they rely on to survive.
“Politicians from both parties have acknowledged the massive toll the opioid crisis has taken on American lives. It’s time for them to back up their rhetoric with action and guarantee that any healthcare bill they send to the President’s desk protects coverage for substance use disorder treatment. Millions of Americans are counting on Congress and President Trump to do the right thing.”
About Gary Mendell:
Gary Mendell is the founder and CEO of Shatterproof. Mr. Mendell founded Shatterproof to spare others the tragedy his family suffered with the loss of his son Brian to addiction in 2011. He is an experienced businessman and CEO, who founded HEI Hotels & Resorts and is the former president of Starwood Lodging Trust.
Shatterproof is a national nonprofit organization dedicated to reducing the devastation the disease of addiction causes families. Shatterproof works to end the stigma and foster a community of support for families by providing evidence-based resources to support prevention, treatment and recovery. Shatterproof also advocates for federal and state policy changes by supporting the development and implementation of evidence-based solutions for substance-use disorders.